The project award from BARDA will aid and accelerate late stage development for a vaccine, with an aim for licensure of a pre-pandemic vaccination against H5 influenza.
4 ways vaccine skeptics mislead you on measles and more
Measles is on the rise in the United States. So far this year, the number of cases is about 17 times what it was, on average, during the same period in each of the four years before.
Sanofi strikes licensing pact with Novavax for COVID, flu-COVID combo shots
Robert F. Kennedy, Jr. apologized to his cousin Bobby Shriver and attempted to distance himself from the Super Bowl ad’s creation — though he still has it pinned to the top of his X profile.
GSK reports positive news on trio of high-profile products
Encouraging developments included an opportunity to build on the blockbuster debut of GSK’s RSV vaccine and the potential return of a previously withdrawn cancer drug.
Making RSV splash, AstraZeneca buys Icosavax in deal worth up to $1.1B